Insider · CIK 0001490662

Rabin Gary H

Reports to the SEC for 1 company · MARLBOROUGH, MA

sec.gov

Transactions

Companies

Filings

CIK

0001490662

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-01-10	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−1M sh	$0.08	−$79.2K	6,000,001
2012-10-23	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−650K sh	$0.07	−$45.6K	7,000,001
2012-10-22	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−350K sh	$0.07	−$25K	7,650,001
2012-09-06	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−391K sh	$0.08	−$32.1K	8,000,001
2012-09-05	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−609K sh	$0.08	−$50K	8,391,445
2012-08-27	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−1M sh	$0.08	−$78.4K	9,000,001
2012-06-29	Ocata Therapeutics, Inc.A Award	Director, CEO & CFO	AAward	+1M sh	—	—	15,262,401
2012-06-15	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−350K sh	$0.07	−$25.4K	10,000,001
2012-06-14	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−350K sh	$0.07	−$25.1K	14,262,401
2012-06-13	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−300K sh	$0.07	−$21.2K	14,612,401
2012-06-11	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−175K sh	$0.07	−$13.1K	14,912,401
2012-05-29	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−24.5K sh	$0.08	−$1,960	10,350,001
2012-05-25	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−80K sh	$0.08	−$6,440	10,374,501
2012-05-24	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−95.5K sh	$0.08	−$7,666.321	10,454,501
2012-05-14	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−388K sh	$0.07	−$26.6K	10,549,972
2012-05-11	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−290K sh	$0.07	−$20.8K	10,938,062
2012-05-07	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−122K sh	$0.08	−$9,821	11,228,062
2012-05-03	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−200K sh	$0.08	−$16.7K	11,350,062
2012-01-23	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−625K sh	$0.18	−$110K	11,549,972
2011-10-14	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−721K sh	$0.14	−$104K	12,174,972
2011-10-13	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−787K sh	$0.14	−$112K	12,895,892
2011-10-12	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−492K sh	$0.15	−$71.4K	13,683,321
2011-08-12	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−540K sh	$0.17	−$91.7K	14,174,971
2011-08-11	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−708K sh	$0.16	−$116K	14,714,958
2011-08-10	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−135K sh	$0.16	−$21.9K	15,422,871
2011-08-09	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−667K sh	$0.17	−$110K	15,557,971
2011-07-01	Ocata Therapeutics, Inc.A Award	Director, CEO & CFO	AAward	+10M sh	—	—	15,087,430
2011-07-01	Ocata Therapeutics, Inc.Stock Options (right to buy)A Award	Director, CEO & CFO	AAward	+10M sh	—	—	10,000,000
2011-07-01	Ocata Therapeutics, Inc.Stock Options (right to buy)A Award	Director, CEO & CFO	AAward	+5M sh	—	—	5,000,000
2011-07-01	Ocata Therapeutics, Inc.Stock Options (right to buy)A Award	Director, CEO & CFO	AAward	+5M sh	—	—	5,000,000
2011-05-20	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−750K sh	$0.20	−$151K	5,087,430
2011-05-04	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−267K sh	$0.19	−$51.9K	16,224,971
2011-04-26	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−733K sh	$0.18	−$130K	16,491,869
2011-03-17	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−4,000 sh	$0.16	−$628	5,837,430
2011-03-15	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−414K sh	$0.15	−$64.2K	6,623,185
2011-03-15	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−782K sh	$0.16	−$128K	5,841,430
2011-02-28	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−391K sh	$0.17	−$68.1K	17,224,971
2011-02-09	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−250K sh	$0.19	−$47.2K	17,615,964
2011-02-07	Ocata Therapeutics, Inc.S Sale	Director, CEO & CFO	SSale	−250K sh	$0.19	−$48.7K	17,865,964
2011-01-03	Ocata Therapeutics, Inc.A Award	Director, CEO & CFO	AAward	+5M sh	—	—	10,890,993
2010-12-14	Ocata Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, CEO & CFO	AAward	+5M sh	—	—	5,000,000
2010-02-04	Ocata Therapeutics, Inc.A Award	Director, CEO & CFO	AAward	+5.89M sh	—	—	5,890,993

Recent filings

Accepted (ET)
Apr 154
Rabin Gary H0001019687-13-001335
SEC(opens sec.gov)

Companies

Ocata Therapeutics, Inc.Director, CEO & CFO

Address

33 LOCKE DRIVE

MARLBOROUGH, MA, 01752